Case report: Medical cannabis—warfarin drug-drug interaction

被引:0
作者
Tyan F. Thomas
Evdokia S. Metaxas
Thu Nguyen
Whitni Bennett
Kathryn V. Skiendzielewski
Diane H. Quinn
Alice L. Scaletta
机构
[1] University of the Sciences,Philadelphia College of Pharmacy
[2] Corporal Michael J. Crescenz VA Medical Center,Department of Pharmacy Practice and Pharmacy Administration
[3] Philadelphia College of Pharmacy (PCP) at University of the Sciences (USciences),undefined
[4] University of the Sciences,undefined
[5] Philadelphia College of Pharmacy,undefined
来源
Journal of Cannabis Research | / 4卷
关键词
Warfarin; Medical cannabis; Anticoagulation; Drug-drug interaction;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 30 条
  • [1] Anderson GD(2016)Pharmacokinetic drug interactions with tobacco, cannabinoids and smoking cessation products Clin Pharmacokinet. 55 1353-1368
  • [2] Chan LN(2021)Δ-9-tetrahydrocannabinol dose increase leads to warfarin drug interaction and elevated INR J Am Pharm Assoc. 61 e57-e60
  • [3] Brown GW(2017)Demographic trends among older cannabis users in the United States, 2006-13 Addiction. 112 516-525
  • [4] Bellnier TJ(2019)Probable interaction between warfarin and inhaled and oral administration of cannabis J Pharm Pract. 18 897190019854958-74
  • [5] Janda M(1997)Human P450 metabolism of warfarin Pharmacol Ther. 73 67-486
  • [6] Han BH(2004)Database analyses for the prediction of Br J Clin Pharmacol. 54 473-76
  • [7] Sherman S(2009) drug-drug interactions from Drug Metab Rev. 41 67-14
  • [8] Mauro PM(2018) data Gerontol Geriatr Med. 4 1-19
  • [9] Hsu A(2018)Pharmacokinetics and drug metabolism in the elderly Eur J Intern Med. 49 12-276
  • [10] Painter NA(2009)Marijuana use among adults 50 years or older in the 21st century Clin Pharmacol Ther. 85 273-300